CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced the company is exhibiting at the 66th Southern Neurosurgical Society (SNS) Annual Meeting being held in Naples, Florida on March 25-28, 2015. Tom Ulich, MD, InVivo’s Chief Scientific Officer, and Lorianne Masuoka, MD, InVivo’s Chief Medical Officer, are presenting intraoperative videos from the company’s ongoing Investigational Device Exemption (IDE) pilot study, which has enrolled two subjects thus far. The videos provide an update to the neurosurgical community on the company’s investigational Neuro-Spinal Scaffold novel implantation techniques, which until InVivo’s pilot study, had never been performed in patients with spinal cord injury.
Help employers find you! Check out all the jobs and post your resume.
